New treatments in sight for challenging neuropsychiatric symptoms in neurodegenerative diseases

FHS
April 4, 2024
2:57 am

Study reviews the advancements in pharmacological treatments for neuropsychiatric syndromes in neurodegenerative disorders, discussing the complexities of managing symptoms such as depression, disinhibition, apathy, psychosis, and agitation to improve patient care.

Google Invests in Ubie to Advance Digital Health Generative AI

What You Should Know: – Ubie Inc., a Japanese health tech company, has announced a significant investment from Google in its latest funding round. –

October 9, 2024

Pfizer’s Ngenla finally secures FDA approval following a rocky road to market – Pharmaceutical Technology

Pfizer and OPKO’s Ngenla will be available in America, having already been approved in 40 other markets. Source: Shutterstock/ShU studio. Pfizer has announced that the

June 28, 2023

Groundbreaking advances in tuberculosis vaccine development and therapies

Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually.

February 11, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.